Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Global Angiogenesis Assays Market Size study, By Product Type (Angiogenesis Tube Formation Assays, Microfluidic Angiogenesis Assays, Endothelial Adhesion, Invasion and Migration Assays), By Application (In Vitro Angiogenesis, In Vivo Angiogenesis), By End User (Angiogenesis Assays for Hospitals, Angiogenesis Assays for Specialty Clinics, Angiogenesis Assays for Ambulatory Surgical Centers), and Regional Forecasts 2022-2028

  • BIZ4983493
  • 200 Pages
  • July 2022
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Global Angiogenesis Assays Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Angiogenesis refers to the process of generating new capillary blood vessels. It is essential for the delivery of oxygen and nutrients to the body's tissues. Angiogenesis is stimulated when tumor tissues require nutrients and oxygen. This abnormal blood vessel growth can be the underlying cause of many deadly and debilitating diseases including cancer, cardiovascular disease, stroke, and diabetic and age-related blindness. angiogenesis assays are utilized to analyze new blood vessel formation for applications of cancer research, tissue regeneration and vascular biology. The rising incidences of cancer disease worldwide and increasing number cancer research investments as well as recent funding activities are factors that are accelerating the global market demand. For instance, according to World Cancer Research Fund International – in 2020, globally total number of cancer cases were estimated at 18.1 million. Out of these around 9.3 million cases were in men and around 8.8 million were in women. Breast and lung cancers were estimated as the most prevalent cancer type worldwide, accounting for 12.5% (2,261,419) and 12.2% (2,206,771) of the total number of new cases diagnosed in 2020. Furthermore, recent funding activities from public sector authorities would influence the growth of Angiogenesis Market. For instance, in January 2022, The Cancer Research UK center granted USD 11.20 million to University of Oxford and the Oxford-based NHS to fund cancer research. Additional USD 3.05 million grant would be intended for training and studentships over the next five years. Also, growing healthcare infrastructure in emerging economies and increasing prevalence of chronic diseases are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, a lack of technical expertise in developing regions coupled with high cost associated with cancer research impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Angiogenesis Assays Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of funding activities towards cancer research and presence of leading market players. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising incidences of chronic disease and rising healthcare spending in the region, would create lucrative growth prospects for the global Angiogenesis Assays Market across the Asia Pacific region.

Major market players included in this report are:

Abcam

Bio-Techne

Thermo Fisher Scientific

Cell Biolabs, Inc.

BioVision, Inc

PromoCell GmbH

Merck KGaA

Kollodis BioSciences

Sartorius (Essen BioScience)

Creative Bioarray

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Angiogenesis Tube Formation Assays

Microfluidic Angiogenesis Assays

Endothelial Adhesion

Invasion and Migration Assays

By Application:

In Vitro Angiogenesis

In Vivo Angiogenesis

By End User:

Angiogenesis Assays for Hospitals

Angiogenesis Assays for Specialty Clinics

Angiogenesis Assays for Ambulatory Surgical Centers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Angiogenesis Assays Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Global Angiogenesis Assays Market, by Region, 2020-2028 (USD Million)

1.2.2. Global Angiogenesis Assays Market, by Product Type, 2020-2028 (USD Million)

1.2.3. Global Angiogenesis Assays Market, by Application, 2020-2028 (USD Million)

1.2.4. Global Angiogenesis Assays Market, by End User, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Angiogenesis Assays Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Angiogenesis Assays Market Dynamics

3.1. Angiogenesis Assays Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Rising incidences of cancer disease worldwide.

3.1.1.2. Increasing number cancer research investments.

3.1.1.3. Recent funding activities.

3.1.2. Market Challenges

3.1.2.1. Lack of technical expertise in developing regions.

3.1.2.2. High cost associated with cancer research.

3.1.3. Market Opportunities

3.1.3.1. Growing healthcare infrastructure in emerging economies.

3.1.3.2. Increasing prevalence of chronic diseases.

Chapter 4. Global Angiogenesis Assays Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Angiogenesis Assays Market, by Product Type

6.1. Market Snapshot

6.2. Global Angiogenesis Assays Market by Product Type, Performance - Potential Analysis

6.3. Global Angiogenesis Assays Market Estimates & Forecasts by Product Type 2018-2028 (USD Million)

6.4. Angiogenesis Assays Market, Sub Segment Analysis

6.4.1. Angiogenesis Tube Formation Assays

6.4.2. Microfluidic Angiogenesis Assays

6.4.3. Endothelial Adhesion

6.4.4. Invasion and Migration Assays

Chapter 7. Global Angiogenesis Assays Market, by Application

7.1. Market Snapshot

7.2. Global Angiogenesis Assays Market by Application, Performance - Potential Analysis

7.3. Global Angiogenesis Assays Market Estimates & Forecasts by Application 2018-2028 (USD Million)

7.4. Angiogenesis Assays Market, Sub Segment Analysis

7.4.1. In Vitro Angiogenesis

7.4.2. In Vivo Angiogenesis

Chapter 8. Global Angiogenesis Assays Market, by End User

8.1. Market Snapshot

8.2. Global Angiogenesis Assays Market by End User, Performance - Potential Analysis

8.3. Global Angiogenesis Assays Market Estimates & Forecasts by End User 2018-2028 (USD Million)

8.4. Angiogenesis Assays Market, Sub Segment Analysis

8.4.1. Angiogenesis Assays for Hospitals

8.4.2. Angiogenesis Assays for Specialty Clinics

8.4.3. Angiogenesis Assays for Ambulatory Surgical Centers

Chapter 9. Global Angiogenesis Assays Market, Regional Analysis

9.1. Angiogenesis Assays Market, Regional Market Snapshot

9.2. North America Angiogenesis Assays Market

9.2.1. U.S. Angiogenesis Assays Market

9.2.1.1. Product Type estimates & forecasts, 2018-2028

9.2.1.2. Application estimates & forecasts, 2018-2028

9.2.1.3. End User estimates & forecasts, 2018-2028

9.2.2. Canada Angiogenesis Assays Market

9.3. Europe Angiogenesis Assays Market Snapshot

9.3.1. U.K. Angiogenesis Assays Market

9.3.2. Germany Angiogenesis Assays Market

9.3.3. France Angiogenesis Assays Market

9.3.4. Spain Angiogenesis Assays Market

9.3.5. Italy Angiogenesis Assays Market

9.3.6. Rest of Europe Angiogenesis Assays Market

9.4. Asia-Pacific Angiogenesis Assays Market Snapshot

9.4.1. China Angiogenesis Assays Market

9.4.2. India Angiogenesis Assays Market

9.4.3. Japan Angiogenesis Assays Market

9.4.4. Australia Angiogenesis Assays Market

9.4.5. South Korea Angiogenesis Assays Market

9.4.6. Rest of Asia Pacific Angiogenesis Assays Market

9.5. Latin America Angiogenesis Assays Market Snapshot

9.5.1. Brazil Angiogenesis Assays Market

9.5.2. Mexico Angiogenesis Assays Market

9.6. Rest of The World Angiogenesis Assays Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Abcam

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Bio-Techne

10.2.3. Thermo Fisher Scientific

10.2.4. Cell Biolabs, Inc.

10.2.5. BioVision, Inc

10.2.6. PromoCell GmbH

10.2.7. Merck KGaA

10.2.8. Kollodis BioSciences

10.2.9. Sartorius (Essen BioScience)

10.2.10. Creative Bioarray

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Angiogenesis Assays Market, report scope

TABLE 2. Global Angiogenesis Assays Market estimates & forecasts by Region 2018-2028 (USD Million)

TABLE 3. Global Angiogenesis Assays Market estimates & forecasts by Product Type 2018-2028 (USD Million)

TABLE 4. Global Angiogenesis Assays Market estimates & forecasts by Application 2018-2028 (USD Million)

TABLE 5. Global Angiogenesis Assays Market estimates & forecasts by End User 2018-2028 (USD Million)

TABLE 6. Global Angiogenesis Assays Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 7. Global Angiogenesis Assays Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 8. Global Angiogenesis Assays Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global Angiogenesis Assays Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global Angiogenesis Assays Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global Angiogenesis Assays Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global Angiogenesis Assays Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global Angiogenesis Assays Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global Angiogenesis Assays Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. Global Angiogenesis Assays Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. U.S. Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 17. U.S. Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 18. U.S. Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 19. Canada Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 20. Canada Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. Canada Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 22. UK Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 23. UK Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. UK Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 25. Germany Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 26. Germany Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. Germany Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 28. RoE Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 29. RoE Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. RoE Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 31. China Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 32. China Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. China Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 34. India Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 35. India Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. India Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 37. Japan Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 38. Japan Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. Japan Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 40. RoAPAC Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 41. RoAPAC Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. RoAPAC Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 43. Brazil Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 44. Brazil Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Brazil Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 46. Mexico Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 47. Mexico Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. Mexico Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 49. RoLA Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 50. RoLA Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. RoLA Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 52. Row Angiogenesis Assays Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 53. Row Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. Row Angiogenesis Assays Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 55. List of secondary sources, used in the study of global Angiogenesis Assays Market

TABLE 56. List of primary sources, used in the study of global Angiogenesis Assays Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370